乙酰半胱氨酸泡騰片聯(lián)合布地奈德福莫特羅吸入粉霧劑治療穩(wěn)定期慢阻肺患者的效果
中圖分類號:R563.9 文獻標(biāo)識碼:A文章編號: 1006-1959(2025)13-0125-05
DOI:10.3969/j.issn.1006-1959.2025.13.024
Abstract:ObetieTvestiateeicalfetofetylystenefervesttabletsombdiudesodendfumarateowerfor inhalationintetreatmentofpatientswithstablehronicbstructivepulmoarydisease.MethodsAtotalof6Opatientswithstablechoic obstructivepulmoarydiseaseadmitedtoHukouCountyPeople'sHospitalfromMarch1toMarch3ereseletedsteresearojects, andtheywerddintootrooududdoubrableetodithtitschop.ooe routinetreatmentndtestudygoupastreatedwithcetylcysteinefervescenttabletsombdwithbudesodendfumarateodefor ialtioni fistsecond(VelosselluaO)ede ∣2) , oxygensaturation(pO)erecomparedbetweenthetwogroups.esultsomparedwithteotalefectiverateofthecontrolgoup(73. % ),the total effectiverate of the study group was higher( 96.67% )(P<0.05).Thelung function indexes(FVC,F(xiàn)EVi/FVC,F(xiàn)EVi) of the two groups after treatmentwerehgerantoeforetreatentndomaedithotrolgouptelungfuctioidees(FVC,F(xiàn)EVCFVf study group after treatment were higher( P <0.05).The level of IL-8in the two groupsafter treatment was lower than that before treatment,and compared with the control group,the level of IL-8 in the study group after treatment was lower( P<0.05) .After treatment, PaO2 andSpC 12 in the two groupswerehgherthantosebeforetreatment,hilePaCOvelwaslowerthanthatbeforetreatment,andcomparedwiththecontrolgroup, PaO2 and SpO2levels in the study group were higher,while PaCC level was lower( P<0.05) .Conclusion The clinical effect of acetylcysteine effervescent tabletsombindidesodendfuaateorforalatioinereantofptitsitsableostuctieuloaseis definite,which canimprovethelung functionand blood gas indexofpatientsandreducetheinflammatoryreaction.
Keywords:Acetylsteescetablets;desoddfumaateodefoalatioStabloicrucieumoai
慢阻肺(chronic obstructive pulmonary disease)是指特征為氣流持續(xù)受限的肺氣腫、支氣管慢性炎癥,可進一步發(fā)展為呼吸衰竭和慢性肺源性心臟病[。(剩余5960字)
-
-
- 醫(yī)學(xué)信息
- 2025年13期
- 基于文獻計量學(xué)的人工智能在中醫(yī)...
- 護理信息系統(tǒng)創(chuàng)新性使用行為的影...
- 智能化集成式綜合預(yù)約平臺的建設(shè)...
- 阜陽地區(qū)乳腺癌患者腋窩淋巴結(jié)轉(zhuǎn)...
- 基于CiteSpace的慢性骨...
- 玉女煎治療糖尿病臨床療效和安全...
- 基于VOSviewer的ERC...
- 維持性血液透析患者自體動靜脈內(nèi)...
- ORCID在醫(yī)學(xué)類中國科技核心...
- 臨床醫(yī)學(xué)完全開放獲取期刊的特征...
- 大數(shù)據(jù)時代基于InCites及...
- 2020年1月-2022年12...
- 智能手機成癮對中國成年人乳腺癌...
- 醫(yī)院服務(wù)應(yīng)用管理系統(tǒng)的設(shè)計與應(yīng)...
- 基于對標(biāo)理論的綜合不良事件管理...
- 科研信息化在醫(yī)院科研人員績效考...
- 基于孟德爾隨機化方法分析炎癥性...
- 不同劑量布地奈德霧化吸入對老年...
- 左炔諾孕酮宮內(nèi)節(jié)育系統(tǒng)聯(lián)合屈螺...
- 阿奇霉素聯(lián)合布地奈德霧化治療小...
- 進展性Wellens綜合征相關(guān)...
- 小骨窗開顱術(shù)與鉆孔引流術(shù)治療高...
- 舒芬太尼配伍羅哌卡因椎管內(nèi)麻醉...
- 乙酰半胱氨酸泡騰片聯(lián)合布地奈德...
- 替格瑞洛聯(lián)合阿司匹林、阿托伐他...
- 阿莫西林聯(lián)合奧美拉唑治療胃炎合...
- 硬通道鉆孔引流術(shù)對慢性硬膜下血...
- 不同劑量利伐沙班治療老年心力衰...
- 桑芩止咳湯聯(lián)合定喘湯加減治療慢...
- 氨茶堿與甲潑尼龍琥珀酸鈉聯(lián)合治...
- CT與MRI在急性腦梗死患者診...
- 益氣化痰方聯(lián)合化療對肺癌患者毒...
- 超聲引導(dǎo)下頸部迷走神經(jīng)阻滯在胸...
- 利培酮片與富馬酸喹硫平片治療首...
- “人工智能+全病程管理”模式在...
- 中醫(yī)特色護理在痰喘散穴位敷貼治...
- 4R危機理論的護理對ICU重癥...
- 多樣化護理措施對于急性闌尾炎手...
- 精細護理在復(fù)雜腎結(jié)石患者行多通...